Australia's largest stock trading and investment forum Australia's #1 stock forum

PAL

Click for more information

0.00%

29.5¢ palla pharma limited

Ann: TPE completes sale of Portugal operations, page-8

First 8 Last

Share
Profile

Follow
Tinwins

15,226 Posts.

522

28/02/18

13:19

Post #: 31414387
Share

K

Originally posted by kensho ↑

I don't know anything about TPE but it appears that they didn't meet a target. A lot of companies have been ruthlessly punished for not meeting expected targets:

From the TPE 2017 Results and 2018 Outlook report:
2. 2H 2017 operating EBITDA of -$3.6m fell short of target.
3. Key drivers of the shortfall were: a. External straw delays: customs and shipping delays on remaining tolling contract volume and Hungary straw. b. Additional operating costs: increased labour in anticipation of greater straw volumes through 4Q 2017 which didn’t eventuate. c. Lower Contract Manufacturing Organisation (‘CMO’) volumes: CPO tablets into the UK. d. Unplanned plant downtime: Norway API production downtime due to unresolved maintenance issue from prior owner impacted first 6 weeks post acquisition.

Expand

Kensho thanks for the summary

TPE Price at posting: $1.45 Sentiment: Hold Disclosure: Held
1 Upvote

0 Great analysis

Reply

There are more pages in this discussion • 23 more messages in this thread...

First 8 Last

Add PAL (ASX) to my watchlist